19d agoBusiness InsiderBEARISH 42General
Kaplan Fox Notifies Cellebrite DI Ltd. (CLBT) Investors of a Securities Investigation into the Company
New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox Kilsheimer LLP is investigating...
Archived explainer. For the current picture see today's CLBT page.
Why Is CELLEBRITE DI LTD A (CLBT) Stock Up Today?
By the Top Tier Newswire AI Desk · August 24, 2026 at 2:08 PM ET · reviewed against 2 wire stories
CELLEBRITE DI LTD A (CLBT) is up +4.43% in the latest session. Our newswire has captured 2 stories on CLBT across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 37/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Cellebrite DI Ltd. (CLBT) shares rose 4.43% to $11.54 in intraday trading on Friday, driven by a wave of legal developments and ongoing analyst coverage. Two separate securities investigations were announced within 24 hours, raising questions about the company's compliance with securities laws and prompting investor speculation about potential outcomes. Despite a broader 8-session price decline of 25.9%, the stock reached a session high of $11.54 at 2:05 PM ET, with volume reaching 1.5 million shares, or 60% of the 3-month average.
What Happened
Kaplan Fox Kilsheimer LLP and Block Leviton both announced investigations into Cellebrite DI for potential securities law violations. These investigations, disclosed within 24 hours, have drawn attention to the company’s recent financial and legal standing. The stock opened at $11.10 and climbed steadily through the session, reflecting investor reactions to the news. Meanwhile, analysts from Lake Street, JP Morgan, DA Davidson, and Needham have maintained Buy or Overweight ratings, albeit with lowered price targets ranging from $12.5 to $16. These adjustments suggest continued optimism about the company’s long-term potential despite recent volatility.
What The Data Shows
The stock has traded within a 52-week range of $9.58 to $19.98 and has a market capitalization of $2.8 billion. Recent insider transactions show three executives, CEO Thomas Hogan, CMO David Nicholas, and Global Chief Revenue Officer Marcus Jewell, selling shares totaling $4.5 million in the last 90 days. The stock has also printed 14 fresh 52-week highs on August 24, indicating some short-term buying interest. However, the broader price trend remains bearish, with the stock down 25.9% over the last eight sessions.
What To Watch
Cellebrite DI is not scheduled to report earnings in the near term. Investors should monitor the breadth of analyst coverage and any new developments from the ongoing securities investigations. The stock’s performance may also be influenced by further insider activity or shifts in institutional sentiment.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
CLBT by the numbers
Last: $11.54Session: +4.43%7 sessions: +9.95%Coverage: 2 stories / 1 sourcesAI sentiment: 37/100 (bearish)Mkt cap: $2.8BP/E: 48.152w: $9.58 to $19.98
The headlines behind the move
19d agoBusiness InsiderBEARISH 32General
Cellebrite Investigated for Securities Fraud by Block & Leviton; CLBT Investors Should Contact the Firm to Possibly Recover Losses
Boston, Massachusetts--(Newsfile Corp. - August 24, 2026) - Block Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in their...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on CLBT: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier CLBT move explainers: 2026-08-24 · 2026-08-18 · 2026-08-17 · 2026-08-13